ARWR - Arrowhead Pharmaceuticals, Inc.

Name: Arrowhead Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Christopher Richard Anzalone	3.79M	$225.78M	-
COO	Patrick O'Brien	547.4K	$32.59M	-
Other	James C Hamilton	227.0K	$13.51M	-
CFO	Daniel Joseph Apel	162.9K	$9.70M	-
Dir	Michael S Perry	111.5K	$6.64M	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 3, 2022	Adeoye Y Olukotun52	Director	Sell	4,050	$64.75	$262,233.04	-45.0%	-27.7%	-45.0%
Dec 28, 2021	Mauro Ferrari71	Director	Sell	3,400	$66.82	$227,188.00	-8.5%	-32.2%	-43.1%
Dec 28, 2021	Douglas B Given66	Director	Buy	655	$66.37	$43,472.35	+0.6%	-32.2%	-43.1%
Dec 15, 2021	Christopher Richard Anzalone60	Chief Executive Officer	Sell	60,000	$67.56	$4,053,431.46	-1.8%	-42.1%	-55.3%
Nov 19, 2021	Martin Javier San65	Chief Medical Officer	Sell	19,500	$69.31	$1,351,589.00	-14.9%	-36.5%	-56.8%
Oct 22, 2021	Christopher Richard Anzalone60	Chief Executive Officer	Sell	65,000	$65.77	$4,274,981.60	-1.9%	-20.5%	-49.4%
Sep 13, 2021	Adeoye Y Olukotun52	Director	Sell	5,000	$63.76	$318,800.00	-35.7%	+11.0%	-44.3%
Sep 9, 2021	Douglas B Given66	Director	Sell	5,000	$65.24	$326,200.00	-4.4%	+13.3%	-40.9%
Jun 24, 2021	Marianne De Backer67	Director	Sell	5,000	$89.85	$449,250.00	-18.9%	-29.9%	-61.5%
Jun 22, 2021	James Hassard61	Chief Commercial Officer	Sell	3,625	$89.22	$323,422.50	-3.3%	-29.8%	-64.5%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC